Early Discharge from the Emergency Department Based on Soluble Urokinase Plasminogen Activator Receptor (suPAR) Levels: A TRIAGE III Substudy.

Martin SchultzLine J H RasmussenThomas Høi-HansenErik KjøllerBirgitte N JensenMorten N LindLisbet RavnThomas KallemoseTheis LangeLars KøberLars Simon RasmussenJesper Eugen-OlsenKasper K Iversen

Published in: Disease markers (2019)

This trial is registered with NCT02643459.

Keyphrases

emergency department
study protocol
phase iii
clinical trial
phase ii
randomized controlled trial
binding protein